| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ESSA Pharma Inc. | Director | Common Shares | 0 | $0 | $0.24 | 09 Oct 2025 | Direct |
| enGene Holdings Inc. | Director | Stock Option (Right to Buy) | 22.5K | 16 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EPIX | ESSA Pharma Inc. | 09 Oct 2025 | 1 | $0 | 4 | Director | 15 Oct 2025, 12:00 |
| ENGN | enGene Holdings Inc. | 16 Jun 2025 | 1 | $0 | 4 | Director | 16 Jun 2025, 18:38 |
| ENGN | enGene Holdings Inc. | 15 Jun 2024 | 1 | $0 | 4 | Director | 18 Jun 2024, 16:06 |
| ENGN | enGene Holdings Inc. | 28 May 2024 | 2 | $107 | 4 | Director | 29 May 2024, 18:12 |
| EPIX | ESSA Pharma Inc. | 24 Apr 2024 | 2 | $18.4K | 4 | Director | 25 Apr 2024, 10:35 |
| EPIX | ESSA Pharma Inc. | 25 Mar 2024 | 1 | $0 | 4 | Director | 28 Mar 2024, 12:33 |
| ENGN | enGene Holdings Inc. | 31 Oct 2023 | 9 | $0 | 4 | Director | 02 Nov 2023, 16:08 |
| ENGN | enGene Holdings Inc. | 31 Oct 2023 | 0 | $0 | 3 | Director | 31 Oct 2023, 18:01 |
| EPIX | ESSA Pharma Inc. | 29 Jun 2022 | 1 | $0 | 4 | Director | 01 Nov 2022, 11:05 |